Natural health product · NPN 80091022
Tamaflex
No: licence discontinued
The licence holder discontinued the product licence.
Licence status Discontinued; licensed February 28, 2019; licence last revised July 28, 2020.
- Natural Product Number (NPN)
- 80091022
- Licence holder
- GNC Canada Holdings ULC
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- February 28, 2019
- Licence last revised
- July 28, 2020
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Tamarindus indica | 75 mg | Seed(s); 90 % Proanthocyanidins; 8:1 extract; equivalent to 600 mg dried herb |
| Curcuma longa | 37.5 mg | Rhizome; 15 % Curcuminoids; 7:1 extract; equivalent to 262.5 mg dried herb |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to improve joint health by reducing knee joint pain, knee joint stiffness and improving physical function associated with daily physical activity. Helps to reduce/relieve knee joint pain associated with daily physical activity. Helps to reduce knee stiffness associated with daily physical activity. Helps to promote joint comfort associated with daily physical activities. Helps to promote joint movement and physical functioning associated with daily physical activity by reducing joint pain and stiffness. Helps to improve ability to perform daily activities by reducing joint stiffness. Helps relieve joint pain associated with daily physical activity in 14 days. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Provides antioxidants for the maintenance of good health.
Non-medicinal ingredients
Silicon dioxide; Microcrystalline cellulose; Hypromellose; Dicalcium phosphate; Magnesium stearate; Calcium silicate